Alger Mid Cap 40 ETF (FRTY)
Live price chart, market sentiment, and community perspectives for Alger Mid Cap 40 ETF (AMEX: FRTY).
Live price chart, market sentiment, and community perspectives for Alger Mid Cap 40 ETF (AMEX: FRTY).
On our desk, evaluating FRTY's market positioning requires keeping a close eye on its high portfolio turnover, which sits at 389.65% compared to a category average of just 91.36%. While the net expense ratio of 0.60% undercuts the broader mid-cap growth category average of 1.05%, the fund's non-diversified nature and tendency to concentrate assets within single sectors demand cautious rotational strategy timing. Weak near- and mid-term sentiment currently pressures a neutral long-term outlook.
Looking at FRTY's fundamental risk profile from a quantitative standpoint, the fund exhibits a 5-year beta of 1.16 relative to the broader market. Under normal circumstances, it invests at least 80% of its net assets in mid-cap equity securities while operating as a non-diversified vehicle. This structure inherently introduces additional risk vectors, which became evident when the fund underperformed the Russell Midcap Growth Index during the first quarter of 2026 with an NAV return of -7.61%.
When discussing portfolio execution protocols for clients eyeing mid-cap growth alternatives like FRTY, I always emphasize the disclosures highlighting that this ETF differs from traditional ETFs and carries distinct structural risks. Even though it managed a YTD daily total return of 12.10% and yields 0.18% with $143.07M in net assets, analysts must account for its concentrated sector bets and high transaction frequency during tactical asset allocation reviews.
Explore plasma cleansing, somatic organ swaps, and BCI.